Merck & Co. Inc. buy UBS Group AG
Start price
08.01.25
/
50%
€96.50
Target price
08.01.26
€116.45
Performance (%)
-10.66%
Price
15.12.25
€85.40
Summary
This prediction is currently active. The prediction for Merck & Co. Inc. disappoints with a performance of -10.66%. Dividends of €0.81 are taken into consideration when calculating the performance. This prediction currently runs until 08.01.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 0.353% | 0.353% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by UBS_Group_AG for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at UBS Group AG from $125.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by UBS_Group_AG for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€104.60
31.07.24
31.07.24
€131.36
31.07.25
31.07.25
-34.80%
01.08.25
01.08.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€117.60
02.02.24
02.02.24
€137.06
02.02.25
02.02.25
-18.88%
03.02.25
03.02.25